Clinical Trial Update: The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease

View source ↗

Summary

A prospective cohort study evaluating the benefit-risk of antithrombotic or anticoagulant therapy in patients with unruptured intracranial aneurysms associated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm
• Ischemic Cerebrovascular Disease
• Ischemic Heart Disease

Drugs mentioned

• Antithrombotic or anticoagulant therapy (class) (antithrombotic/anticoagulant therapy)

Snippet

Sponsor: Liu Zhiyong | Conditions: Intracranial Aneurysm, Natural History | Status: UNKNOWN